REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 28 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $53,000 | -44.8% | 103,100 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $96,000 | +1.1% | 103,100 | +94.2% | 0.00% | 0.0% |
| Q3 2018 | $95,000 | +26.7% | 53,100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $75,000 | -6.2% | 53,100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $80,000 | -20.8% | 53,100 | +6.0% | 0.00% | 0.0% |
| Q4 2017 | $101,000 | – | 50,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Benin Management CORP | 14,300 | $25,000 | 0.01% |
| Virtu Financial LLC | 52,912 | $94,000 | 0.01% |
| WEDBUSH SECURITIES INC | 25,500 | $45,000 | 0.01% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 4,000 | $7,000 | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 34,767 | $62,000 | 0.00% |
| A.R.T. Advisors, LLC | 11,406 | $20,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 53,100 | $95,000 | 0.00% |
| Capital Advisory Group Advisory Services, LLC | 900 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 406 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 82,605 | $147,000 | 0.00% |